rna

News

Novartis makes $12bn wager on RNA drugs with Avidity buy

Novartis is poised to make one of its largest takeover deals in its history after agreeing to buy RNA specialist Avidity Biosciences for $12bn.

News

Novo reels in Replicate for new cardiometabolic drugs

Replicate will receive up to $550m from Novo Nordisk in an alliance that aims to deliver a new generation of drugs for obesity and diabetes.

News

Daiichi Sankyo taps Depixus to speed RNA drug discovery

Daiichi Sankyo has made the development of RNA-based therapeutics and vaccines one of the pillars of its R&D operations and has turned to start-up Depixus to accelerat

R&D

Partner Content

6th RNA-Targeted Drug Discovery & Development Summit – Decem...

200+ Attendees | 33+ World-Class Speakers | 23+ Data Driven Case Studies

News

Aera Tx launches with $193m in financing for genetic meds

Aera Therapeutics announces launch with $193m financing from leading life sciences investors.

Oncology

Partner Content

2nd Next Generation RNA Therapeutics Summit

Bringing Next Generation RNA Therapies to Patients Fast

Novartis makes $12bn wager on RNA drugs with Avidity buy

Novo reels in Replicate for new cardiometabolic drugs

Daiichi Sankyo taps Depixus to speed RNA drug discovery

6th RNA-Targeted Drug Discovery & Development Summit – Decem...

Aera Tx launches with $193m in financing for genetic meds

2nd Next Generation RNA Therapeutics Summit

OpenBind unveils its first AI model for drug discovery

Discover a new era of healthcare panel engagement: Grounded ...

rna

Editor's Picks